America’s biopharmaceutical companies’ have acted quickly to focus their expertise on treatments for COVID-19. Currently, treatments being tested range from antiviral and antibody therapies to anticoagulant and antimicrobial therapies – to target both the virus itself and the most dangerous health consequences of COVID-19.
Please join PhRMA member company executives for a townhall on COVID-19 therapeutic development – a unique forum to hear directly from leaders in the fight to beat COVID-19, including:
Ramona Sequeira,President, Takeda
David Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company
Alexander Hardy, Chief Executive Officer, Genentech
Johanna Mercier, Chief Commercial Officer, Gilead
If you wish to submit a question for the panel, please use the registration link or email firstname.lastname@example.org by close of business Friday, July 17th.